Form D Explorer

Form D — Rezo Therapeutics, Inc.

0001853446-25-000004 · filed Aug 18, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$80,129,936
Reported amount sold
$68,066,039
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Rezo Therapeutics, Inc.
CIK
1956559
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2021
Address
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
Phone
415-310-4524

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗